PRESENTATION

Q4 2020 — Earnings presentation

Q4 2020PDF · 22 pages694 KB
2020
Fourth Quarter
Business Review
and 2021 Outlook
(Unaudited)
January 26, 2021

-- 1 of 22 --

2
2020 Q1 Earnings – April 28, 2020. All rights reserved.
Events
2021 Earnings Calls
Q1 April 27, 2021
Q2 July 27, 2021
Q3 October 26, 2021

-- 2 of 22 --

3
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Forward looking statement
This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and
uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe,"
"will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial
performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic,
political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or
climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic
associated with the coronavirus (COVID-19); (3) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and
chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (4) legal proceedings, including
significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended
Dec. 31, 2019, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (5) competitive conditions and customer preferences; (6) foreign currency
exchange rates and fluctuations in those rates; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased
components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply
interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of
a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10)
the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity
improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement
plans; and (13) the Company's credit ratings and its cost of capital. Changes in such assumptions or factors could produce significantly different results. A
further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in
Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The
information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements
contained in this presentation as a result of new information or future events or developments.
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s January 26, 2021 press release for descriptions of non-GAAP financial
measures such as adjusted free cash flow, adjusted free cash flow conversion, return on invested capital (ROIC), net debt, adjusted EBITDA, and various
measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures.
Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release.
Note on non-GAAP financial measures

-- 3 of 22 --

4
2020 Q4 Earnings – January 26, 2021. All rights reserved.
• Continuing to fight the COVID-19 pandemic from every angle
• Strong Q4: broad-based growth, improved margins, robust cash flow
• 2020: executed well while transforming for the future
• Accelerating investments in growth, productivity, and sustainability
• Initiating full-year 2021 guidance; well positioned for growth
Protecting employees, serving customers and delivering for shareholders
3M is delivering and well positioned for the future

-- 4 of 22 --

5
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 2020 performance: strong finish to the year
Sales of $8.6B, up 5.8% year-on-year
• Organic growth across all business segments and geographic
areas
• COVID-related respirator sales growth of ~$280M, or +3.5
ppts contribution to total company sales growth
End-market trends year-on-year
• Strength: personal safety, home improvement, semiconductor,
data center, home cleaning and biopharma filtration
• Weakness: hospitality, healthcare and oral care elective
procedures, healthcare IT and office supplies
Adjusted EBITDA margins of 27.3%, up 260 bps year-on-year
Adjusted free cash flow of $2.1B, up 16% year-on-year
Reduced net debt by $1.3B, or 9% sequentially
5.5%
year-on-year
Organic local-
currency growth
$2.38
+22.1% year-on-year
Adjusted earnings
per share
21.5%
+2.5 ppts year-on-
year
Adjusted operating
margin

-- 5 of 22 --

6
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 2020 P&L
$8.6B
+5.8% year-on-year
Net sales
$1.8B
+20.1% year-on-year
Adjusted operating
income
$1.4B
+22.4% year-on-year
Adjusted net
income
Q4 2019 19.0%
Organic volume/
productivity
and other
+1.6%
Organic volume growth; disciplined cost
management/productivity; Q4 2020 gain
on sale of properties (+0.6%); increase in
respirator mask reserve (-0.9%)
Acquisitions/divestitures +0.1% Primarily drug delivery divestiture
Price/raw material +0.8% Selling prices up 0.8% year-on-year; lower
raw material costs
FX -0.1% Net of hedge impact
Restructuring +0.1% Pre-tax charge Q4 2020 $137M vs. Q4
2019 $134M
Q4 2020 21.5%
Adjusted operating income margin reconciliation:

-- 6 of 22 --

7
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Adjusted earnings per share reconciliation:
Q4 2019 $1.95
Organic growth/
productivity
and other
+$0.43
Organic sales growth; disciplined cost
management/productivity; Q4 2020 gain
on sale of properties (+$0.09); increase in
respirator mask reserve (-$0.10)
Acquisitions/divestitures -$0.02 Primarily drug delivery divestiture
FX +$0.02 Pre-tax earnings impact of +$13M
Restructuring $0.00 Pre-tax charge Q4 2020 $137M vs. Q4
2019 $134M
Other expense/shares
outstanding -$0.03 Primarily higher net interest (including
early debt retirement)
Tax rate* +$0.03 Underlying tax rate; rate benefited by
geographic mix of pre-tax income
Q4 2020 $2.38
Q4 2020 adjusted EPS
+9.0%
$2.38
+22.1% year-on-year
Adjusted earnings
per share 
* The effect of income taxes on items that had specific tax rates are reflected within their respective
impacts in the table above.

-- 7 of 22 --

8
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 2020 cash flow and balance sheet
Adjusted free cash flow of $2.1B, up 16% year-on-year
• FY 2020: $6.7B, up 18% year-on-year
Adjusted free cash flow conversion of 151%
• FY 2020: 132%, up 22 ppts vs. last year
Capital expenditures:
• Q4 2020: $422M, down $116M year-on-year
• FY 2020: $1.5B, down $198M year-on-year
Net debt:
• Q4 2020 $13.7B vs. Q3 2020 $15.0B, down 9%
• YE 2020 $13.7B vs. YE 2019 $17.8B, down 23%
Cash returned to shareholders
• FY 2020: $3.8B in cash dividends paid and share
repurchases
$2.1B Adjusted free
cash flow
$5.1B Cash & marketable
securities
$0.8B Dividends

-- 8 of 22 --

9
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 Business Group performance
Sales
Organic growth
Segment
Operating
Margin
Change
Commentary
Change
Safety &
Industrial
$3.1B
+11.4%
27.7%
+6.9 ppts
• Organic sales grew in personal safety, roofing granules, industrial adhesives and tapes, and
electrical markets; declined automotive aftermarket, abrasives, and closure and masking systems
• Organic sales growth benefited by 9.9 ppts due to pandemic related respirator mask demand
• Segment operating margin improvement driven by sales growth, strong productivity, continued
spending discipline and property sale gain
Transportation
& Electronics
$2.3B
+1.4%
21.8%
+1.0 ppts
• Organic sales grew in automotive and aerospace, transportation safety, electronics, and
advanced materials; declined in commercial solutions
• Segment operating margin improvement driven by continued spending discipline
Health Care $2.3B
+6.6%
24.7%
+3.4 ppts
• Organic sales grew in medical solutions, separation and purification, and food safety; declined in
oral care and health information systems
• Segment operating margin improvement driven by continued spending discipline, partially offset
by higher restructuring costs
Consumer $1.4B
+9.9%
23.5%
Flat
• Organic sales grew in home improvement, home care, and consumer healthcare; declined in
stationery and office supplies
• Segment operating margins improvement driven by sales growth and strong productivity, offset
by increased investments in ad merch, new product innovation, and higher restructuring costs

-- 9 of 22 --

10
2020 Q4 Earnings – January 26, 2021. All rights reserved.
2020 full-year performance
-1.7% Organic local
currency growth
$8.74 Adjusted earnings
per share
18.2% Return on
invested capital
132% Adjusted free cash
flow conversion
• Delivered for our customers and generated adjusted free
cash flow of $6.7 billion
• Expanded adjusted EBITDA margins to 27.2%, up 100
basis points year-on-year
• Strength and resiliency of operating model and
disciplined capital allocation enabled $4.1 billion
reduction in net debt
• Strengthened Health Care portfolio; executed integration
of Acelity and completed drug delivery divestiture
• Returned $3.8 billion to shareholders via cash dividends
and share repurchase
• 2020 marked the 62nd consecutive year of increase in
annual dividend
Executed well and delivered strong cash flow

-- 10 of 22 --

11
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Delivering today, building for a stronger tomorrow
Fought the pandemic from every angle
• Produced and delivered 2 billion respirators; expanded
production capacity to 2.5 billion units
• Helped speed vaccine and therapeutic development
• Partnered with governments to maintain PPE supply
Executed for customers and end markets where demand
was strong
• Personal safety; home improvement; semiconductor; data
centers; general cleaning; biopharma filtration
Advanced business model and invested in efficiency,
productivity, and growth
• Increased pace of innovation; expanded partnerships
• Delivered strong supply chain execution despite
macroeconomic disruption and uncertainty
• Initiated restructuring actions to reduce annual operating
costs by $250 million to $300 million

-- 11 of 22 --

12
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Positioned for strong 2021 performance
Accelerating investments in growth, productivity and sustainability
• Forecasting organic sales growth of 3 to 6 percent, improvement in
margins and earnings, and strong cash flow generation
• Prioritizing investments in end markets where demand is strong and
sustainable … personal safety, health care, auto OEM, semiconductor,
data center, and home improvement … and Priority Growth Platforms
• Optimizing business group-led global operating model, business
processes, and streamlining global organization
• Accelerating pace of manufacturing technology deployment
• Advancing operating rigor through end-to-end digitization and
leveraging data and data analytics
• Stepping up ESG leadership: enhancing sustainability including air and
water stewardship; advancing diversity, equity and inclusion

-- 12 of 22 --

13
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Full-year 2021 planning estimates
Sales growth of 5% to 8%:
• Organic local-currency: 3% to 6%
• Divestitures: approx. -0.5%
• Foreign currency translation: approx. 2%
Disciplined capital allocation:
• Cap-ex: $1.8B to $2.0B
• Pension contributions: $0.1B to $0.2B
• Restarting share repurchase program
Continue to strengthen capital structure and
financial flexibility
3% to 6% Organic local
currency growth
$9.20 to
$9.70
Earnings
per share
95% to
105%
Free cash
flow conversion

-- 13 of 22 --

14
2020 Q4 Earnings – January 26, 2021. All rights reserved.
2021 organic local-currency growth segment expectations
Business Groups Organic Growth Macroeconomic/End-Market Factors
Safety &
Industrial
Mid-single
digits
• Pace and success of vaccine deployment and adoption
• 2021 global GDP and IPI expected up mid-single digits
• Semiconductor; data center; consumer electronic device demand
• Car & light truck builds
• Disposable respirator demand
• Return-to-workplace/return-to-school trends
• Healthcare and oral care elective procedure volumes
• Retail sales and e-commerce strength
• Home improvement trends
Transportation &
Electronics
Low to high-
single digits
Health Care Low to mid-
single digits
Consumer Low to mid-
single digits
Total 3M: 3% to 6%

-- 14 of 22 --

15
2020 Q1 Earnings – April 28, 2020. All rights reserved.
Q&A
Mike Roman
Chairman and
Chief Executive Officer
Monish Patolawala
Senior Vice President and
Chief Financial Officer
Bruce Jermeland
Vice President,
Investor Relations

-- 15 of 22 --

16
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Appendix

-- 16 of 22 --

17
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 2020 P&L
($M)
Q4
2019
Q4
2020 Change
Sales $8,111 $8,583 +5.8%
Gross profit $3,786 $4,195 +10.8%
% to sales 46.6% 48.8% +2.2 pts
SG&A $1,940 $1,890 -2.6%
% to sales 23.9% 22.0% -1.9 pts
R&D & related $521 $456 -12.4%
% to sales 6.4% 5.3% -1.1 pts
Operating income $1,325 $1,849 +39.5%
% to sales 16.3% 21.5% +5.2 pts
Net income $969 $1,389 +43.4%
GAAP earnings per share $1.66 $2.38 +43.4%

-- 17 of 22 --

18
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Q4 2020 sales recap
Americas EMEA Asia
Pacific
Organic volume +6.6% +3.8% +2.1%
Price +1.3% +1.8% -0.4%
Organic local-currency +7.9% +5.6% +1.7%
Acquisitions/Divestitures -0.9% -3.2% -0.2%
FX -1.2% +5.0% +3.8%
Total growth +5.8% +7.4% +5.3%
U.S. Canada Mexico Brazil China Japan
Organic local-currency +9% +2% Flat +21% +14% -4%

-- 18 of 22 --

19
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Business segment information
($M) Net Sales Q4 2020 Sales Growth
Organic local-currency
by Geographic Area
Business Segment Operating
Income/Adjusted Operating
Income*
Business Segment
Operating Margin
/Adjusted Operating
Margin*
Business groups
Q4
2019
Q4
2020
Organic
local-
currency FX M&A
Total
Sales
change Americas
Asia
Pacific EMEA
Q4
2019
Q4
2020
Percent
Change
Q4
2019
Q4
2020
Safety & Industrial $2,785 $3,140 11.4% 1.3% 0.0% 12.7% 15% 2% 14% $579 $869 49.9% 20.8% 27.7%
Transportation &
Electronics $2,286 $2,338 1.4% 2.2% -1.3% 2.3% -1% 3% Flat $474 $511 7.5% 20.8% 21.8%
Health Care $2,141 $2,257 6.6% 1.6% -2.8% 5.4% 9% flat 7% $457 $558 22.3% 21.3% 24.7%
Consumer $1,289 $1,425 9.9% 0.7% 0.0% 10.6% 13% -2% 9% $303 $335 10.7% 23.5% 23.5%
Elimination of Dual
Credit ($402) ($577) ($101) ($150)
Total Operating
Business Segment $1,712 $2,123
Corporate and
Unallocated $12 --- ($173) ($274)
Total $8,111 $8,583 5.5% 1.4% -1.1% 5.8% 7.9% 1.7% 5.6% $1,539 $1,849 20.1% 19.0% 21.5%
Organic local-currency = organic volume + price
* “Corporate and Unallocated” and “Total” provided on an adjusted basis

-- 19 of 22 --

20
2020 Q4 Earnings – January 26, 2021. All rights reserved.
Sales by division
($M) Net Sales
Business groups Q4 2019 Q4 2020
Abrasives 328 317
Automotive Aftermarket 312 306
Closure and Masking Systems 276 248
Electrical Materials 288 292
Industrial Adhesives and Tapes 648 689
Personal Safety 851 1,212
Roofing Granules 73 95
Other Safety & Industrial 9 (19)
Total Safety & Industrial Business Group 2,785 3,140
Advanced Materials 284 266
Automotive & Aerospace Solutions 450 487
Commercial Solutions 403 382
Electronics 951 996
Transportation Safety 202 212
Other Transportation & Electronics (4) (5)
Total Transportation & Electronics Business Group 2,286 2,338
($M) Net Sales
Business groups Q4 2019 Q4 2020
Drug Delivery 95 -
Food Safety 87 90
Health Information Systems 324 307
Medical Solutions 1,120 1,315
Oral Care 330 335
Separation & Purification 189 214
Other Health Care (4) (4)
Total Health Care Business Group 2,141 2,257
Consumer Health Care 84 88
Home Care 244 270
Home Improvement 568 664
Stationery and Office 370 364
Other Consumer 23 39
Total Consumer Business Group 1,289 1,425
Corporate and Unallocated 12 -
Elimination of Dual Credit (402) (577)
Total 8,111 8,583

-- 20 of 22 --

21
2020 Q4 Earnings – January 26, 2021. All rights reserved.
0.40 to 0.70 (0.05) 0.15
(0.10) to
neutral (0.35) to (0.45)
0.20 to 0.35
0.20 to 0.30 Neutral
Growth and
Portfolio Management Raw Materials & Productivity Other
Financial
$8.74
2021 EPS roadmap
$9.20
to
$9.70

-- 21 of 22 --



-- 22 of 22 --